Scientific Division

Apolipoproteins by Mass Spectrometry (WG-APO MS)

Membership

Name	Position	Country	Term	Time in Office
C. Cobbaert	Chair	NL	2nd	2020 01 - 2022 12
U. Ceglarek	Member	DE
V. Delatour	Member	FR
J. Dittrich	Member	DE
C. Hirtz	Member	FR
A. Hoofnagle	Member	US
Z. Kuklenyik	Member	US
L.R. Ruhaak	Member	NL
H.W. Vesper	Member	US
H. Althaus	IVD Representative/Siemens	DE
U. Prinzing	IVD Representative/Roche	DE
G.M. Kostner	Consultant	AT
F. Kronenberg	Consultant	AT
H. Schimmel	Consultant	BE
I. Zegers	Consultant	BE

Terms of Reference

To achieve standardization of a panel of clinically relevant serum apolipoproteins (apo) A-I, B, C-I, C-II , C-III, E and apo (a) (including qualitative phenotyping where needed). Standardization is done in such a way that measurement results are traceable to SI as outlined in ISO 17511. Other traceability chains will be used in cases where traceability to SI cannot be achieved.
To evaluate clinical performance and clinical utility of serum apolipoprotein panel(s) for CVD risk stratification and treatment, in comparison to or together with contemporary blood lipids.

Current projects

Define the analytes / measurands intended to be measured.
Development of primary and secondary reference materials, including evaluation of commutability.
Development of an LC-MS/MS-based reference method for the above mentioned analytes that are unaffected by genetic variants, post-translational modifications and other factors. The reference method will meet relevant ISO standards (i.e., ISO 15195).
Evaluation of the analytical performance of the LC-MS/MS reference method.
Assessment of the performance of commercially available apolipoprotein assays compared to the reference method using commutable reference materials as well as single donation samples.
Any reference materials and reference measurement procedures developed will be submitted to JCTLM for review and listing on the JCTLM database.

Future Projects

Evaluation of clinical performance and clinical utility of the multiplexed apolipoprotein test according to the Test Evaluation framework developed by the EFLM working group on Test Evaluation (Horvath AR et al., CCA, 2014).

List of Corresponding Members, nominated by National Societies

Name	Full and Affiliate Member Societies
Huseyin Kayadibi	Turkish Biochemical Society (TBS)

Working Group Chair's contact

Prof. Christa COBBAERT
Head of Department Clinical Chemistry
and Laboratory Medicine LUMC
Afd. KCL
postroute E2-P
P.O. Box 9600
2300 RC Leiden
The Netherlands
E-mail: C.M.Cobbaert@lumc.nl